Want to track 1548 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
1548 closed today higher at 24.54 HKD, an increase of 1.5728% from yesterday's close, completing a monthly increase of 96.32% or 12.04 HKD. Over the past 12 months, 1548 stock gained 97.9032%.
1548 is not paying dividends to its shareholders.
The last earnings report, released on Mar 27, 2026, exceeded the consensus estimates by 0.2335%. On average, the company has surpassed earnings expectations by 0.0778%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on HKEX (HKD).
GenScript Biotech Corporation (1548) FAQ
What is the stock price today?
The current price is 24.54 HKD.
On which exchange is it traded?
GenScript Biotech Corporation is listed on HKEX.
What is its stock symbol?
The ticker symbol is 1548.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 24.48B.
Has GenScript Biotech Corporation ever had a stock split?
No, there has never been a stock split.
GenScript Biotech Corporation Profile
| Biotechnology Industry | Healthcare Sector | Mr. Jiange Meng CEO | HKEX Exchange | G3825B105 CUSIP |
| DE Country | 5,769 Employees | - Last Dividend | - Last Split | - IPO Date |
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through three segments: Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products. The Life Science Services and Products segment provides products and services in various categories, including gene synthesis, oligonucleotide synthesis, peptide synthesis, protein engineering, antibody development, and life-science equipment and consumables, such as molecular diagnostics tools and genome editing materials for biology studies, pharmaceutical and drug discovery, disease diagnostics and vaccine, agriculture, environmental studies, and the food industry. The Biologics Development Services segment which helps biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene/cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment develops and produces industrial enzymes through non-pathogenic microbial strains constructed using genetic engineering. Genscript Biotech Corporation was founded in 2002 and is headquartered in Nanjing, the People's Republic of China.
Contact Information
Address: Jiangning Science Park, Nanjing, China, 211100
Phone: 86 25 5889 7288
Website: https://www.genscript.com
